KLK3 and prostate carcinoma: Similar to KLK3, also Kallikrein related peptidase 2 (KLK2) functions in hydrolyzing seminogelins and is regulated by androgen receptor [55], upregulated in prostate tumor cells, and recognized as potential prognostic maker for prostate cancer risk [56].